Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensyne Health was a UK-based clinical artificial intelligence company focused on using anonymized patient data and real-world evidence to accelerate medical research and improve patient care. Its main offerings included remote patient monitoring solutions like GDm‑Health™ for diabetes management during pregnancy and the SENSIGHT research/data analysis platform. The company partnered with major pharma companies such as Roche and Bayer to support drug discovery through advanced data analytics. In early 2022 Sensyne entered administration due to financial difficulties; its core assets were subsequently acquired by Artrya Ltd.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sensyne Health.